Open Email Discussions

The purpose of email discussions is to share information about medicines and practice in NSW public hospitals. NSW TAG members are encouraged to respond to email discussion requests for information. However, it should be noted that information is only a current snapshot at the time the response is sent. The responses received are only representative of the hospitals participating in the discussion at the time (which may be small depending on the topic) and do not indicate a complete picture of current practices. It is recommended that email discussion topics are regularly brought to the attention of DTC meetings as they are likely to facilitate discussion of contemporary and emerging medicines and practice.

  • Open email discussions

    Please provide email discussions responses to NSW TAG

  • Formulary status of carbetocin

    A member has enquired whether hospitals are listing carbetocin on formulary and with what restrictions?

    Please respond by COB 24th August 2020

  • Ketamine in acute pain

    An enquiry has been received regarding the use of ketamine in acute pain.

    1. Does your facility have an acute pain guideline?
    2. Is ketamine included in these guidelines and where does it fit in the workflow (e.g. second line, third line)?  Are there any restrictions for its use?
    3. Please provide your local acute pain guideline if applicable

    Please respond by COB 21st August 2020

Completed email discussions can be found here (members only).

Access to completed email discussions is only available to NSW TAG members. Please note, members should not share or pass on identifiable information to non-NSW TAG members. Non-NSW TAG members who are interested in an email discussion topic may obtain de-identified email discussions by contacting NSW TAG at

A list of the current open email discussions is shown below.

  • Recently Completed Email Discussions

    • Topical anaesthetics on formulary
    • Use of coloured patient ID bands
    • Local policy for Medicines Access Programs approvals
    • Navigating the PBS
    • Dual antiplatelet dispensing post PCI
    • Use of povidone iodine in theatres
    • Nifedipine for tocolysis
    • Managing medication shortages
    • 2020 Vaccine management issues
    • COVID-19 guideline development for handling patient’s own and hospital issued medications
    • Nicotine replacement therapy inhalers on formulary
    • Rapid sequence intubation (RSI) kits for COVID-19 patients
    • Use of very high cost medicines in those transitioning from paediatric to adult hospitals


    Click here to access the email discussions running list of topics (last updated 28/07/2020).

    Click here to access the completed email discussions page (members only).

Page last updated 13 August 2020